By Deena Beasley Nov 3 (Reuters) - Amgen on Tuesday said third-quarter sales rose 8%, led by demand for cholesterol drug ...

By Deena Beasley Nov 3 (Reuters) - Amgen on Tuesday said third-quarter sales rose 8%, led by cholesterol drug Repatha and ...

US biotech major Amgen reported third-quarter 2026 revenues of $10.37 billion, up 8% year-on-year and ahead of analyst ...

Amgen (NASDAQ:AMGN) reported third-quarter revenue growth of 8% year over year to $10.4 billion, supported by broad-based ...

Amgen reported strong Q3 2026 results, with revenue of US$10.37b, GAAP net income of US$3.86b, and raised full year guidance ...

Biopharma industry veteran Jackie Elbonne, Ph.D., is retiring at the end of the year, leaving Amgen’s top quality spot to her ...

Amgen has been handed an FDA warning letter over a video promoting its cancer drug Vectibix, but the company said the issues ...

Amgen reported third-quarter revenue of about $10.4 billion, up roughly 8%, and adjusted earnings of $6.45 per share, as ...

Amgen's quarterly revenue swings between $8.1B and $10.1B, while Vertex climbs steadily from $2.8B to $3.3B—a tale of scale ...

Amgen appears safe, but the current valuation above $450/share may prove expensive by Q3 2026. Click here to read an analysis of AMGN stock now.

Amgen Inc. ( AMGN) Q3 2026 Earnings Call November 3, 2026 4:30 PM EST My name is Julianne, and I will be your conference facilitator today for the Amgen Q3 2026 Earnings Conference Call. [Operator ...

Oct 20 (Reuters) - Amgen and AstraZeneca said on Tuesday their asthma drug helped reduce swallowing difficulties and achieved disease remission in 69% of patients with a type of chronic inflammatory ...